Cytokinetics, Incorporated · NASDAQ:CYTK

Malik Fady Ibraham sold 3,500 Cytokinetics, Incorporated shares (Form 4)

Traded Jun 23, 2026 · Filed Jun 23, 2026

On Jun 23, 2026, Malik Fady Ibraham (EVP Research & Development) sold 3,500 Cytokinetics, Incorporated shares at US$79.51 for US$278K under a trading plan, leaving 153,902 shares. Filed Jun 23, 2026 (Form 4).

Sold
3,500 shares
Price
US$79.51
Value
US$278K
Holding after
153,902 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP Research & Development

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 23, 2026Common StockOption exercise3,500US$7.80157,402Direct
Jun 23, 2026Common StockSale3,500US$79.51153,902Direct

Source

View original at SEC

Related